SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007468
Filing Date
2022-05-05
Accepted
2022-05-04 18:02:34
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20220331.htm   iXBRL 10-Q 2141079
2 EX-31.1 acad-ex31_1.htm EX-31.1 13226
3 EX-31.2 acad-ex31_2.htm EX-31.2 13448
4 EX-32.1 acad-ex32_1.htm EX-32.1 9629
5 EX-32.2 acad-ex32_2.htm EX-32.2 9673
  Complete submission text file 0000950170-22-007468.txt   7885170

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acad-20220331_lab.xml EX-101.LAB 328257
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acad-20220331_pre.xml EX-101.PRE 243512
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acad-20220331_cal.xml EX-101.CAL 53477
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acad-20220331_def.xml EX-101.DEF 111088
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acad-20220331.xsd EX-101.SCH 41447
53 EXTRACTED XBRL INSTANCE DOCUMENT acad-20220331_htm.xml XML 1734629
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 22893112
SIC: 2834 Pharmaceutical Preparations